Skip to content
Disclosery

13F-HR filed by SUPERSTRING CAPITAL MANAGEMENT LP

SUPERSTRING CAPITAL MANAGEMENT LP filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 37 holding rows worth $151,235,764.

Accession
0001931118-24-000007
Filer
CIK 1931118
Filed
2024-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2024

A holdings report, 37 entries on the cover page, a total value of $151,235,764 stated on the cover page (in dollars after the unit check, H1), rows summing to $151,235,764 with VALUE read as dollars as filed, 13F file number 028-23866. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CYTOKINETICS INC23282W605COM NEW278,915$19,554,730dollars as filed
NKARTA INC65487U108COMMON STOCK1,189,193$12,855,176dollars as filed
89BIO INC282559103COM941,287$10,956,580dollars as filed
BRIDGEBIO PHARMA INC10806X102COM353,507$10,930,436dollars as filed
SAVARA INC805111101COM2,065,144$10,284,417dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock217,070$9,525,031dollars as filed
FATE THERAPEUTICS INC31189P102COM920,476$6,756,294dollars as filed
Day One Biopharmaceuticals Inc23954D109Common Stock349,679$5,776,697dollars as filed
ROIVANT SCIENCES LTDG76279101SHS531,019$5,596,940dollars as filed
IONIS PHARMACEUTICALS INC COM462222100Stock120,896$5,240,842dollars as filed
MARINUS PHARMACEUTICALS INC56854Q200COM NEW565,550$5,112,572dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK290,797$4,960,997dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK288,267$4,324,005dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS259,383$4,173,472dollars as filed
AEROVATE THERAPEUTICS INC008064107COM110,264$3,260,506dollars as filed
APOGEE THERAPEUTICS INC COM03770N101Stock44,868$2,981,479dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock36,607$2,921,239dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock99,822$2,833,947dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW40,119$2,448,061dollars as filed
ALLOGENE THERAPEUTICS INC019770106COM521,249$2,329,983dollars as filed
KEROS THERAPEUTICS INC COM492327101Stock33,828$2,239,413dollars as filed
PYXIS ONCOLOGY INC COMMON STOCK747324101Stock493,759$2,103,414dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR12,754$1,928,022dollars as filed
PEPGEN INC COM713317105Stock114,385$1,681,460dollars as filed
Tourmaline Bio Inc89157D105Common Stock69,972$1,602,359dollars as filed
ALLAKOS INC01671P100COM1,233,739$1,554,512dollars as filed
CYTOMX THERAPEUTICS INC23284F105COMMON STOCK679,403$1,481,099dollars as filed
ANNEXON INC03589W102COM155,728$1,116,569dollars as filed
AVIDITY BIOSCIENCES INC COM05370A108Stock37,031$945,031dollars as filed
LYRA THERAPEUTICS INC55234L105COM145,284$903,667dollars as filed
INOZYME PHARMA INC45790W108COM112,739$863,581dollars as filed
AURINIA PHARMACEUTICALS INC COM05156V102Stock98,691$494,443dollars as filed
KALVISTA PHARMACEUTICALS INC483497103COM32,025$379,817dollars as filed
ALPINE IMMUNE SCIENCES INC02083G100COM9,038$358,267dollars as filed
SPRUCE BIOSCIENCES INC85209E109COM440,225$345,973dollars as filed
LAKESHORE BIOPHARMA CO LTDG9845F109COM307,920$215,544dollars as filed
SO YOUNG INTERNATIONAL INC83356Q108SPONSORED ADS182,742$199,189dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001931118-24-000007this filing2024-05-15acceptance time not in the bulk data set